DaVita Inc.
DaVita Inc. is a leading provider of kidney care services in the United States. It specializes in dialysis treatment and related healthcare support for patients.
Join Our Programs
Our clients trust us for our expert advice and in-depth market analysis. Discover our services to gain more knowledge on investing.
Stock Market Webinar
Join our Stock Market Webinar to gain clear, actionable insights into current market trends. Learn how to analyse data, interpret signals, and make informed investment decisions with confidence. Designed for both beginners and experienced investors, this session delivers practical knowledge you can apply immediately.
Performance
In 2024, DaVita Inc. reported consolidated revenues of $12.816 billion, a 4.7% increase year-over-year, and net income of $936 million, up 35.4% from 2023. The company achieved adjusted operating income of $1.98 billion, with adjusted earnings per share (EPS) of $9.68, reflecting a 26% growth from the previous year. In the fourth quarter, DaVita generated $3.295 billion in revenue and $565 million in operating income, with adjusted EPS of $2.24, marking a 12.3% year-over-year increase. Despite challenges such as supply chain disruptions and increased patient care costs, DaVita’s strategic initiatives and operational efficiencies contributed to its strong financial performance.
Quality of Earnings
The company demonstrates strong adherence to General Accounting Principles, with financial reports that conform to GAAP, are decision-useful, sustainable, and offer returns exceeding the cost of capital. There have been no recent changes to accounting policies, and all required financial reports are submitted on time. Revenue quality is also robust, marked by high predictability—with a substantial portion of clients returning year after year—strong profitability with gross margins exceeding 70%, diversified income sources with no client accounting for more than 15% of revenue, and clear growth in both revenue and net income. Additionally, there are no significant financial report warning signs: earnings contain minimal accrual components, do not narrowly beat benchmarks in a suspicious pattern, and revenue is not recognized prematurely. Expenses are not misrepresented, audit opinions are unqualified, goodwill is properly assessed, and the company does not rely on aggressive accounting tactics such as related-party transactions or off-balance-sheet debt. Operating ccash flows align with net income, earnings are recurring and persistent, and there is no history of restatements or enforcement actions, reinforcing the reliability and quality of the company’s financial reporting.
Company Summary
DaVita Inc. is a leading U.S.-based healthcare provider specializing in kidney care, operating over 3,100 outpatient dialysis centers across 11 countries and serving more than 240,000 patients globally.
